Cost-Effectiveness of Dapagliflozin as Add-On to Insulin for the Treatment of Type 2 Diabetes in the Netherlands
van Haalen, H.G.M., Pompen, M., Bergenheim, K., McEwan, P., Townsend, R., Roudaut, M.Volume:
16
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2013.08.678
Date:
November, 2013
File:
PDF, 58 KB
english, 2013